⌘K

Home/Filings/4/0001213900-20-005549

4//SEC Filing

Gilliland Robertson H. 4

Accession 0001213900-20-005549

CIK 0001513525other

View on SEC.gov Company Profile

Filed

Mar 4, 7:00 PM ET

Accepted

Mar 5, 7:22 PM ET

Size

5.5 KB

Accession

0001213900-20-005549

Insider Transaction Report

Form 4

Period: 2020-03-03

ADIAL PHARMACEUTICALS, INC.ADIL

Gilliland Robertson H.

Director

Transactions

Award
Stock Option
2020-03-03+60,000→ 60,000 total
Exercise: $1.44From: 2020-04-03Exp: 2030-03-02→ Common Stock (60,000 underlying)

Footnotes (1)

[F1]These options vest pro rata on a monthly basis over 36 months.

Documents

1 file

4
ownership.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

ADIAL PHARMACEUTICALS, INC.

CIK 0001513525

Entity typeother

Related Parties

1

filerCIK 0001718351

Filing Metadata

Form type: 4
Filed: Mar 4, 7:00 PM ET
Accepted: Mar 5, 7:22 PM ET
Size: 5.5 KB

View on SEC.gov